Adverum Biotechnologies Inc (NASDAQ:ADVM) price on Friday, May 02, rose 4.80% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $3.49.
A look at the stock’s price movement, the close in the last trading session was $3.33, moving within a range at $3.38 and $3.6. The beta value (5-Year monthly) was 1.091. Turning to its 52-week performance, $10.84 and $2.64 were the 52-week high and 52-week low respectively. Overall, ADVM moved -18.08% over the past month.
Adverum Biotechnologies Inc’s market cap currently stands at around $72.91 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Apr-14.
Wall Street analysts have also projected the company’s year-on-year revenue to grow to 135.71k, representing a -86.43% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ADVM is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 1 recommend ADVM as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ADVM’s current price about 8.37% and -13.43% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 49.83, while 7-day volatility ratio is 11.11% and 11.63% in the 30-day chart. Further, Adverum Biotechnologies Inc (ADVM) has a beta value of 0.83, and an average true range (ATR) of 0.37. Analysts have given the company’s stock an average 52-week price target of $10, forecast between a low of $10 and high of $10. Looking at the price targets, the low is -186.53% off current price level while to achieve the yearly target high, price needs to move -186.53%. Nonetheless, investors will most likely welcome a -186.53% jump to $10 which is the analysts’ median price.
If we refocus on Adverum Biotechnologies Inc (NASDAQ:ADVM), historical trading data shows that trading volumes averaged 0.7 over the past 10 days and 253.96K over the past 3 months. The company’s latest data on shares outstanding shows there are 20.85 million shares.
The 33.59% of Adverum Biotechnologies Inc’s shares are in the hands of company insiders while institutional holders own 60.97% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.43 million on 2025-04-15, giving us a short ratio of 8.69. The data shows that as of 2025-04-15 short interest in Adverum Biotechnologies Inc (ADVM) stood at 687.0 of shares outstanding, with shares short falling to 1.48 million registered in 2025-03-14. Current price change has pushed the stock -25.27% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ADVM stock continues to rise going into the next quarter.
